Microbiome revolution

Understanding the Microbiome

At YSOPIA Bioscience, we strongly believe that the gut microbiome – as it plays a crucial role in human health – is the next paradigm-shift in medicine and a tremendous hope for patients.

“The composition of the microbiome and its activities are involved in most, if not all, of the biological processes that constitute human health and disease.” M. J. Blaser in J. Clin. Invest. (2014). 

Microbiome is a “hidden organ” which controls our health. Bacteria shape their host and are precious partners, playing a central role in a myriad of essential functions in our body – such as metabolism, digestion, immune and neurological functions – through different pathways.

Our gut microbiome is like a virgin forest: a complex and diverse ecosystem which functions in symbiosis with our body. Our modern life, characterized by unhealthy diet, pollution, stress and chemical exposure, can strongly deteriorate this symbiosis. 

> Discover our pipeline

At the Root of Chronic Diseases

Countless studies have recently established the strong links between a disbalance of the microbiome and the development of chronic diseases. In this context, the best way to target the root causes of the disease is by treating this disbalance.

In today’s world, one in three adults suffer from multiple chronic conditions. There is an urgent need to better address chronic diseases.

Chronic diseases are complex and result from a combination of genetic, physiological, environmental and behavioural factors. Despite their complexity, they all share one common feature: an imbalance of microbiome, called dysbiosis, scientifically established as a cause of these diseases.

 

Microbiome & us
News
Jun 1, 2021
90 seconds to learn more about YSOPIA Bioscience | [playlist type="video" ids="2641"]
> more
May 4, 2021
We are looking for a Senior Scientist in Microbiology & Biotechnology – Team Leader position | WHAT WE...
> more
Press / Media
May 24, 2021
Sur un marché mondial estimé à deux milliards de dollars d’ici à 2030, la filière du microbiome pharma veut...
> more
Mar 4, 2021
Read the full article    
> more
Publications
Jun 1, 2021
Camille Kropp, Katy Le Corf, Karima Relizani, Kevin Tambosco, Ccori Martinez, Florian Chain, Georges Rawadi, Philippe...
> more
Apr 6, 2021
Mazier W., Le Corf K., Martinez C., Tudela H., Kissi D., Kropp C., Coubard C., Soto M., Elustondo F., Rawadi G., Claus...
> more
now on twitter
YSOPIA Bioscience

A pilot #study led by Professor Phillip Popovich has placed focus on how traumatic spinal cord injuries might impac… t.co/ENN4WsTnKU

YSOPIA Bioscience © 2021 - all rights reserved terms and conditions